Clinical updates, including trial initiations, enrollment status and data readouts and publications: ProMIS Neurosciences.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Heartbeam, Octave, Quest, RapidAI.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: A2z Radiology, Boston Scientific, Cleveland Diagnostics, Mediview.

The top 10 med-tech stock gainers and losers for the week.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biogen, BMS, Eisai, Innovent, Novartis, Otsuka, Regeneron, Sanofi, Sarepta, Teva.

Biopharma happenings, including deals and partnerships, and other news in brief: Geneditbio, Gilead, Liora, Lixte, Lunai, Psyence, Sprint, Toolgen.

Clinical updates, including data readouts and publications: Ascentage, Junshi, Novo Nordisk.

Biopharmas raising money in public or private financings, including: Faron, Nuvalent, Pharmacyte, Tempest, Zetagen.